OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current, emerging, and potential therapies for non-alcoholic steatohepatitis
Zhen Yang, Lin Wang
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15

Showing 15 citing articles:

Relationship between iron and lipid peroxidation in ferroptosis and effect of ferroptosis in metabolic dysfunction-associated steatotic liver disease
Meng-Juan Ma, Jie Lin, Hongju Yang, et al.
Shijie huaren xiaohua zazhi (2025) Vol. 33, Iss. 1, pp. 34-42
Closed Access

Relationship between iron and lipid peroxidation in ferroptosis and effect of ferroptosis in metabolic dysfunction-associated steatotic liver disease
Meng-Juan Ma, Jie Lin, Hongju Yang, et al.
Shijie huaren xiaohua zazhi (2025) Vol. 33, Iss. 1, pp. 28-36
Closed Access

Exercise, weight maintenance, and nonalcoholic fatty liver disease risk: a Chinese cohort study
Chao Yang, Peijing Yan, Jiaqi Deng, et al.
Frontiers in Physiology (2024) Vol. 15
Open Access | Times Cited: 2

Dose Finding for ZSP1601 in Patients with Nonalcoholic Steatohepatitis Using Population pharmacokinetics and Exposure–Response Approach
Haijun Li, Yue Hu, Yuting Yang, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 199, pp. 106808-106808
Open Access | Times Cited: 2

Hepatic Macrophages as Targets for the MSC-Based Cell Therapy in Non-Alcoholic Steatohepatitis
И. В. Холоденко, K. N. Yarygin
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3056-3056
Open Access | Times Cited: 6

PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease
Vatsal Sachan, Maïlys Le Dévéhat, Anna Roubtsova, et al.
Metabolism (2023) Vol. 150, pp. 155736-155736
Open Access | Times Cited: 5

The obeticholic acid can positively regulate the cancerous behavior of MCF7 breast cancer cell line
R. Rahmani, Neda Eivazi, Solaleh Emamgholipour, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1

Unlocking the Therapeutic Potential of Ellagic Acid for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
Tharani Senavirathna, Armaghan Shafaei, Ricky R. Lareu, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 485-485
Open Access | Times Cited: 1

Mapping global research trends: Nutrition associations with nonalcoholic fatty liver disease - a Scopus bibliometric analysis
Muna Shakhshir, Sa’ed H. Zyoud
World Journal of Gastroenterology (2024) Vol. 30, Iss. 24, pp. 3106-3119
Open Access | Times Cited: 1

Non-alcoholic fatty liver disease in patients with type 2 diabetes: diagnostic and therapeutic considerations
E. Paraschou, Almog Shalit, Stavroula Α. Paschou
HORMONES (2023) Vol. 23, Iss. 3, pp. 415-417
Open Access | Times Cited: 2

Molecular docking targeting autophagy pathway mediate abrogation of NASH by specific functional foods: update review
Merehan Alaa-ElDin. Mohamed, Shaimaa Rihan, M. M. Mahmoud, et al.
Natural Product Research (2024), pp. 1-24
Closed Access

Neutrophils in MASLD and MASH
Haram Lee, Meyer J. Friedman, Sang Bum Kim, et al.
BMB Reports (2024)
Open Access

Page 1

Scroll to top